Skip to main content

Peer Review reports

From: Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families

Original Submission
29 Jul 2015 Submitted Original manuscript
25 Nov 2015 Reviewed Reviewer Report - Carl F. Marrs
14 Dec 2015 Reviewed Reviewer Report - Qian Gao
21 Jan 2016 Author responded Author comments - George Kasule
Resubmission - Version 2
21 Jan 2016 Submitted Manuscript version 2
18 Mar 2016 Author responded Author comments - George Kasule
Resubmission - Version 3
18 Mar 2016 Submitted Manuscript version 3
Publishing
29 Mar 2016 Editorially accepted
21 Apr 2016 Article published 10.1186/s12879-016-1487-1

You can find further information about peer review here.

Back to article page